Search results for: 'Digitalization of Pharma Value Chain'

The value-based care (VBC) model aims to offer better outcomes and care quality to patients cost-effectively. Multiple stakeholders, including payers, healthcare providers, and medical technology (medtech) players, can share the revenue risk and incentive for providing better value. The United States is a pioneer in VBC adoption, followed by countr...

According to the Centers for Medicare and Medicaid Services (CMS), value-based care (VBC) programs reward healthcare providers with incentive payments for the quality of care they provide Medicare patients. These programs are part of its larger CMS quality strategy to reform healthcare delivery and payment. Value-based programs support 3 aims: b...

The research service primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights into the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalization of key processes ac...

Frost & Sullivan defines digital health as data application for healthcare delivery using computational and telecommunication technologies to support business process workflow, clinical workflow, and patient data management. Digital health aims to achieve better patient outcomes while improving efficiency and containing costs through provider and p...

08 Mar 2022  |  North America  |  Market Outlook

Global Pharmaceuticals Outlook, 2022

The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders

Infographics

×

Key Issues Addressed

Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...

17 Nov 2020  |  North America  |  Market Research

Business Models Focusing on Patient Centricity Driving Incremental Value in the Global Digital Patient Engagement Solutions Market, 2025

Growth Strategies to Revolve Around Value-based Care and Population Health Management Initiatives

Infographics

×

Healthcare is evolving, more so after the Coronavirus 2019 (COVID-19) pandemic that hit us in the beginning of 2020. Over time, we have seen surveys that indicate that patients want more control of their healthcare and be active participants of their treatment decisions. Innovations in technology and recent developments in the healthcare ecosystem ...

Hospitals are under extreme pressure to reduce or cut costs and become more profitable. Operating rooms (ORs) drive approximately 60% of revenue in the average hospital. The most critical hospital issues entail finding new methods to reduce human errors and improve efficiency and quality of surgical care. New technology is now available to help hos...

Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...

04 Sep 2018  |  North America  |  Market Research

Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018

Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities

Infographics

×

Key Issues Addressed

The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally en...